A phase II study to determine the response to second curettage as initial management for persistent \

Osborne, Ray

Late Breaking Abstract 2
A phase II study to determine the response to second curettage as initial management for persistent "low-risk" non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study

Monday, March 24, 2014: 8:38 AM

Ballroom B/C (Tampa Convention Center)

R. J. Osborne¹, V. L. Filiaci², R. S. Mannel³, S. A. Davidson⁴, J. S. Hoffman⁵, N. M. Spirtos⁶, J. K. Chan⁷, J. C. Schink⁸, J. Tidy⁹ and D. S. Miller¹⁰
¹University of Toronto, Toronto, ON, Canada, ²Gynecologic Oncology Group Statistical and Data Center, Buffalo, NY, ³University of Oklahoma Health Sciences Center, Oklahoma City, OK, ⁴University of Colorado Denver, Aurora, CO, ⁵New Britain General Hospital, Plainville, CT, ⁶Women's Cancer Center, Las Vegas, NV, ⁷UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, ⁸Northwestern University Feinberg School of Medicine, Chicago, IL, ⁹Royal Hallamshire Hospital, Sheffield, United Kingdom, ¹⁰The University of Texas Southwestern Medical Center, Dallas, TX

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

Late Breaking Abstract 2
A phase II study to determine the response to second curettage as initial management for persistent "low-risk" non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study

Late Breaking Abstract 2 A phase II study to determine the response to second curettage as initial management for persistent "low-risk" non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study

Late Breaking Abstract 2
A phase II study to determine the response to second curettage as initial management for persistent "low-risk" non-metastatic gestational trophoblastic neoplasia: A Gynecologic Oncology Group study